ARS-1
RELIEF-CSU1
Phase 2 small_molecule completed
Quick answer
ARS-1 for Urticaria is a Phase 2 program (small_molecule) at ARS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARS Pharmaceuticals
- Indication
- Urticaria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed